Status:
COMPLETED
Changes in the Consumption of Psychoactive Substances During Containment Linked to COVID-19
Lead Sponsor:
University Hospital, Montpellier
Conditions:
People Incarcerated
COVID-19
Eligibility:
All Genders
18+ years
Brief Summary
The SARS-CoV 2 pandemic started in China in December 2019, then reached France on January 24, 2020. On March 14, France moved into phase 3 of the epidemic threshold with the implementation of contain...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Men incarcerated at Villeneuve Les Maguelone prison
- On a given date (May 12)
- Major
- French speaking
- non illiterate
- Exclusion criteria:
- minors
- patients refusing
- non-French speaking
- illiterate
Exclusion
Key Trial Info
Start Date :
May 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2020
Estimated Enrollment :
700 Patients enrolled
Trial Details
Trial ID
NCT04380714
Start Date
May 1 2020
End Date
August 1 2020
Last Update
December 29 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UH Montpellier
Montpellier, France, 34295